Literature DB >> 7686895

Trabecular cells of the eye express messenger RNA for transforming growth factor-beta 1 and secrete this cytokine.

R C Tripathi1, J Li, N S Borisuth, B J Tripathi.   

Abstract

PURPOSE: To determine whether trabecular tissue in vivo and cultured trabecular cells have the messenger RNA transcript for transforming growth factor-beta 1 (TGF-beta 1), and to examine whether these cells synthesize and secrete TGF-beta 1 in vitro.
METHODS: Total RNA was isolated from the trabecular meshwork, iris, and ciliary body freshly excised from porcine eyes as well as from cultured trabecular cells, and the reverse transcriptase-polymerase chain reaction and Southern hybridization were used for detection of TGF-beta 1 messenger RNA. The amount of TGF-beta 1 secreted by trabecular cells in culture was determined by radioimmunoassay.
RESULTS: Excised whole trabecular tissue, iris, and ciliary body, as well as cultured trabecular cells expressed messenger RNA transcripts for TGF-beta 1. On the ethidium bromide-stained agarose gel, two PCR-amplified products (161 and 400 base pairs) were found in the total RNA isolated from cultured trabecular cells. The oligonucleotide probe specific for TGF-beta 1 detected only one band with the expected length of 161 base pairs. The secretion of TGF-beta 1 into conditioned medium was at the level of 16.7-20 pg/ml per 2 million trabecular cells during a 24-hr period.
CONCLUSIONS: These investigations show that the trabecular meshwork, iris, and ciliary body in vivo express the messenger RNA transcript for TGF-beta 1, and that trabecular cells in vitro synthesize and secrete this cytokine. The TGF-beta 1 present in normal aqueous humor may be derived locally, at least in part, from the cells of the trabecular meshwork, iris, and ciliary body. Abnormal synthesis, secretion, activation, and clearance of TGF-beta 1 may contribute to the pathogenesis of many ocular disorders, including primary open-angle glaucoma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686895

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Innervation of the porcine ciliary muscle and outflow region.

Authors:  Christian Albrecht May; Liliana Maria Skorski; Elke Lütjen-Drecoll
Journal:  J Anat       Date:  2005-03       Impact factor: 2.610

2.  Induction of TGF-beta1 in the trabecular meshwork under cyclic mechanical stress.

Authors:  P B Liton; X Liu; P Challa; D L Epstein; P Gonzalez
Journal:  J Cell Physiol       Date:  2005-12       Impact factor: 6.384

3.  The aqueous levels of TGF-beta2 in patients with glaucoma.

Authors:  Altan Atakan Ozcan; Nusret Ozdemir; Abdullah Canataroglu
Journal:  Int Ophthalmol       Date:  2004-01       Impact factor: 2.031

4.  Presence of an established calcification marker in trabecular meshwork tissue of glaucoma donors.

Authors:  Wei Xue; Núria Comes; Teresa Borrás
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-07       Impact factor: 4.799

5.  TGF-β induces phosphorylation of phosphatase and tensin homolog: implications for fibrosis of the trabecular meshwork tissue in glaucoma.

Authors:  Nikoleta Tellios; Jillian C Belrose; Alexander C Tokarewicz; Cindy Hutnik; Hong Liu; Andrew Leask; Michael Motolko; Miho Iijima; Sunil K Parapuram
Journal:  Sci Rep       Date:  2017-04-11       Impact factor: 4.379

6.  Role of ID Proteins in BMP4 Inhibition of Profibrotic Effects of TGF-β2 in Human TM Cells.

Authors:  Avani A Mody; Robert J Wordinger; Abbot F Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-02-01       Impact factor: 4.799

Review 7.  The role of epigenetics in the fibrotic processes associated with glaucoma.

Authors:  Fiona McDonnell; Colm O'Brien; Deborah Wallace
Journal:  J Ophthalmol       Date:  2014-03-31       Impact factor: 1.909

8.  The Association between TGF-β1 G915C (Arg25Pro) Polymorphism and the Development of Primary Open Angle Glaucoma: A Case-Control Study.

Authors:  Efthymios Karmiris; Nikos Kourtis; Malena P Pantou; Dimitris Degiannis; Ilias Georgalas; Dimitrios Papaconstantinou
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2018
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.